The world is talking about ending AIDS. AVAC’s advocacy is dedicated to realizing that vision. To get there we must:
Updates to AVAC’s Global PrEP Tracker are in for Q3 2020, showing that overall global uptake continued to climb even in the midst of COVID-19. The number of people who have started on PrEP has reached 773,474, an increase of more than 23 percent since the year began. This figure includes countries where the burden of HIV is high, such as Kenya and South Africa, and despite the impact of COVID-19 on healthcare systems.
COVID-19 has devastated communities and health systems around the world – but it has also created an historic global effort leading to the unprecedented development of more than 165 potential vaccines against COVID-19. Equally impressive innovations are speeding vaccine testing within a rigorous scientific framework, while manufacturing and transportation capacity are being scaled up to distribute millions of doses of future COVID vaccines to those who need them most.
Developing COVID-19 vaccines at “pandemic speed” depends on an unprecedented global research effort and on innovative strategies to shorten the vaccine testing and distribution timeline. Speed is important, but not at the expense of ethics, safety, robust engagement, equitable access and scientific rigor.
The latest estimates for COVID-19 anticipate a death toll approaching 2.8 million by year’s end. Global health leaders of every stripe struggle to sustain the gains against HIV, TB, malaria, other preventable diseases and unintended pregnancies. Advocates must be armed with information and tools to demand transparency, and to get effective interventions for both HIV and COVID-19 developed and distributed equitably. Read on for recently produced resources to help get the job done.
AVAC has an extensive online resource library with hundreds of Reports, Publications, Infographics & more. And it includes powerful search features to find exactly what you’re looking for.
AVAC uses education, policy analysis, advocacy, community mobilization and a network of global collaborations to accelerate ethical development and global delivery of biomedical HIV prevention options. Read more
AVAC advocates for a comprehensive response to the epidemic, involving smart use of every proven HIV prevention option available today and sustained research into many new strategies.